IBDEI36H ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50745,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,50745,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,50746,0)
 ;;=D53.9^^193^2497^181
 ;;^UTILITY(U,$J,358.3,50746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50746,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,50746,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,50746,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,50747,0)
 ;;=D47.4^^193^2497^182
 ;;^UTILITY(U,$J,358.3,50747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50747,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,50747,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,50747,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,50748,0)
 ;;=D59.1^^193^2497^29
 ;;^UTILITY(U,$J,358.3,50748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50748,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Other
 ;;^UTILITY(U,$J,358.3,50748,1,4,0)
 ;;=4^D59.1
 ;;^UTILITY(U,$J,358.3,50748,2)
 ;;=^5002324
 ;;^UTILITY(U,$J,358.3,50749,0)
 ;;=D51.3^^193^2497^196
 ;;^UTILITY(U,$J,358.3,50749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50749,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Other
 ;;^UTILITY(U,$J,358.3,50749,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,50749,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,50750,0)
 ;;=D77.^^193^2497^58
 ;;^UTILITY(U,$J,358.3,50750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50750,1,3,0)
 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
 ;;^UTILITY(U,$J,358.3,50750,1,4,0)
 ;;=4^D77.
 ;;^UTILITY(U,$J,358.3,50750,2)
 ;;=^5002396
 ;;^UTILITY(U,$J,358.3,50751,0)
 ;;=D58.2^^193^2497^84
 ;;^UTILITY(U,$J,358.3,50751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50751,1,3,0)
 ;;=3^Hemoglobinopathies,Other
 ;;^UTILITY(U,$J,358.3,50751,1,4,0)
 ;;=4^D58.2
 ;;^UTILITY(U,$J,358.3,50751,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,50752,0)
 ;;=C88.8^^193^2497^106
 ;;^UTILITY(U,$J,358.3,50752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50752,1,3,0)
 ;;=3^Malig Immunoproliferative Diseases,Other
 ;;^UTILITY(U,$J,358.3,50752,1,4,0)
 ;;=4^C88.8
 ;;^UTILITY(U,$J,358.3,50752,2)
 ;;=^5001750
 ;;^UTILITY(U,$J,358.3,50753,0)
 ;;=D70.8^^193^2497^179
 ;;^UTILITY(U,$J,358.3,50753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50753,1,3,0)
 ;;=3^Neutropenia,Other
 ;;^UTILITY(U,$J,358.3,50753,1,4,0)
 ;;=4^D70.8
 ;;^UTILITY(U,$J,358.3,50753,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,50754,0)
 ;;=D59.4^^193^2497^180
 ;;^UTILITY(U,$J,358.3,50754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50754,1,3,0)
 ;;=3^Nonautoimmune Hemolytic Anemias,Other
 ;;^UTILITY(U,$J,358.3,50754,1,4,0)
 ;;=4^D59.4
 ;;^UTILITY(U,$J,358.3,50754,2)
 ;;=^5002326
 ;;^UTILITY(U,$J,358.3,50755,0)
 ;;=D69.59^^193^2497^186
 ;;^UTILITY(U,$J,358.3,50755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50755,1,3,0)
 ;;=3^Secondary Thrombocytopenia,Other
 ;;^UTILITY(U,$J,358.3,50755,1,4,0)
 ;;=4^D69.59
 ;;^UTILITY(U,$J,358.3,50755,2)
 ;;=^5002369
 ;;^UTILITY(U,$J,358.3,50756,0)
 ;;=C22.7^^193^2497^47
 ;;^UTILITY(U,$J,358.3,50756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50756,1,3,0)
 ;;=3^Carcinomas of Liver,Other Spec
 ;;^UTILITY(U,$J,358.3,50756,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,50756,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,50757,0)
 ;;=D75.89^^193^2497^57
 ;;^UTILITY(U,$J,358.3,50757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50757,1,3,0)
 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
 ;;^UTILITY(U,$J,358.3,50757,1,4,0)
 ;;=4^D75.89
